LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis

Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. DNA hypomethylation, particularly of Long Interspersed Nuclear Element-1 (LINE-1) repetitive sequences, has been implicated in CRC development and progression. The purpose of this meta-analysis and systematic review wa...

Full description

Saved in:
Bibliographic Details
Main Authors: Akbar Bagheri, Tohid Jafari-Koshki, Leila Alizadeh, Mortaza Raeisi, Yaghoub Moaddab, Abbas Karimi
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S240584402500790X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199462335643648
author Akbar Bagheri
Tohid Jafari-Koshki
Leila Alizadeh
Mortaza Raeisi
Yaghoub Moaddab
Abbas Karimi
author_facet Akbar Bagheri
Tohid Jafari-Koshki
Leila Alizadeh
Mortaza Raeisi
Yaghoub Moaddab
Abbas Karimi
author_sort Akbar Bagheri
collection DOAJ
description Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. DNA hypomethylation, particularly of Long Interspersed Nuclear Element-1 (LINE-1) repetitive sequences, has been implicated in CRC development and progression. The purpose of this meta-analysis and systematic review was to evaluate the prognostic value of LINE-1 methylation level in patients with CRC. Relevant studies were identified through systematic database searches, and summary hazard ratios (HRs) with 95 % confidence intervals (CIs) were calculated for relations between LINE-1 hypomethylation and overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS). The current systematic review protocol was registered on International Prospective Register of Systematic Reviews (PROSPERO, CRD42024496615). A total of 19 studies comprising 8169 CRC patients were included. The pooled analysis showed no significant association between LINE-1 hypomethylation and OS in the overall population (HR = 1.70, 95 % CI: 0.97–2.96). However, in stage II/III patients, LINE-1 hypomethylation was significantly associated with poorer OS (HR = 1.92, 95 % CI: 1.26–2.91) and DFS (HR = 2.81, 95 % CI: 1.33–5.93). No significant association was found between LINE-1 hypomethylation and CSS (HR = 1.39, 95 % CI: 0.68–2.83). Substantial heterogeneity was observed across studies. The study suggests that LINE-1 methylation level could be a valuable prognostic biomarker for advanced-stage CRC patients, potentially improving personalized care and highlighting areas for future research to establish standardized methodologies.
format Article
id doaj-art-ef16d904c68c4361baced984d6b4091e
institution Kabale University
issn 2405-8440
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-ef16d904c68c4361baced984d6b4091e2025-02-08T05:00:43ZengElsevierHeliyon2405-84402025-02-01113e42410LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysisAkbar Bagheri0Tohid Jafari-Koshki1Leila Alizadeh2Mortaza Raeisi3Yaghoub Moaddab4Abbas Karimi5Department of Molecular Medicine, Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, IranMolecular Medicine Research Center (MMRC), Department of Statistics and Epidemiology, Faculty of Health, Tabriz University of Medical Sciences, Tabriz, IranGastroenterology and Liver Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, IranHematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, IranGastroenterology and Liver Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Molecular Medicine, Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Corresponding author. Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences. Golgasht St., Tabriz, East Azerbaijan, 5166614756, Iran.Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. DNA hypomethylation, particularly of Long Interspersed Nuclear Element-1 (LINE-1) repetitive sequences, has been implicated in CRC development and progression. The purpose of this meta-analysis and systematic review was to evaluate the prognostic value of LINE-1 methylation level in patients with CRC. Relevant studies were identified through systematic database searches, and summary hazard ratios (HRs) with 95 % confidence intervals (CIs) were calculated for relations between LINE-1 hypomethylation and overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS). The current systematic review protocol was registered on International Prospective Register of Systematic Reviews (PROSPERO, CRD42024496615). A total of 19 studies comprising 8169 CRC patients were included. The pooled analysis showed no significant association between LINE-1 hypomethylation and OS in the overall population (HR = 1.70, 95 % CI: 0.97–2.96). However, in stage II/III patients, LINE-1 hypomethylation was significantly associated with poorer OS (HR = 1.92, 95 % CI: 1.26–2.91) and DFS (HR = 2.81, 95 % CI: 1.33–5.93). No significant association was found between LINE-1 hypomethylation and CSS (HR = 1.39, 95 % CI: 0.68–2.83). Substantial heterogeneity was observed across studies. The study suggests that LINE-1 methylation level could be a valuable prognostic biomarker for advanced-stage CRC patients, potentially improving personalized care and highlighting areas for future research to establish standardized methodologies.http://www.sciencedirect.com/science/article/pii/S240584402500790XColorectal cancerLong interspersed nuclear element-1MethylationSurvival
spellingShingle Akbar Bagheri
Tohid Jafari-Koshki
Leila Alizadeh
Mortaza Raeisi
Yaghoub Moaddab
Abbas Karimi
LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis
Heliyon
Colorectal cancer
Long interspersed nuclear element-1
Methylation
Survival
title LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis
title_full LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis
title_fullStr LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis
title_full_unstemmed LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis
title_short LINE-1 methylation status and survival outcomes in colorectal cancer patients: A systematic review and meta-analysis
title_sort line 1 methylation status and survival outcomes in colorectal cancer patients a systematic review and meta analysis
topic Colorectal cancer
Long interspersed nuclear element-1
Methylation
Survival
url http://www.sciencedirect.com/science/article/pii/S240584402500790X
work_keys_str_mv AT akbarbagheri line1methylationstatusandsurvivaloutcomesincolorectalcancerpatientsasystematicreviewandmetaanalysis
AT tohidjafarikoshki line1methylationstatusandsurvivaloutcomesincolorectalcancerpatientsasystematicreviewandmetaanalysis
AT leilaalizadeh line1methylationstatusandsurvivaloutcomesincolorectalcancerpatientsasystematicreviewandmetaanalysis
AT mortazaraeisi line1methylationstatusandsurvivaloutcomesincolorectalcancerpatientsasystematicreviewandmetaanalysis
AT yaghoubmoaddab line1methylationstatusandsurvivaloutcomesincolorectalcancerpatientsasystematicreviewandmetaanalysis
AT abbaskarimi line1methylationstatusandsurvivaloutcomesincolorectalcancerpatientsasystematicreviewandmetaanalysis